Application of liquid chromatography/mass spectrometry and nuclear magnetic resonance to the identification of degradates of a novel insulin sensitizer in aqueous solutions

被引:2
作者
Wang, MH [1 ]
Wu, YH [1 ]
Hwang, TL [1 ]
Qin, XZ [1 ]
Karki, S [1 ]
Treemaneekarn, V [1 ]
机构
[1] Merck Res Labs, W Point, PA 19486 USA
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2004年 / 810卷 / 02期
关键词
insulin sensitizer; thiazolidine-2,4-dione; degradation; dimerization;
D O I
10.1016/j.jchromb.2004.07.034
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Degradation of a novel insulin sensitizer in aqueous solutions was studied using high pressure liquid chromatography/mass spectrometry (LC/MS). The insulin sensitizer, containing a thiazolidine-2,4-dione (TZD), was a new class of antidiabetic agent for the treatment of type 11 diabetes. Chemical stability of the insulin sensitizer was evaluated by stressing its aqueous solutions at 40degreesC for 24 h. Oxygen was removed from one of the solutions by bubbling pure nitrogen through to identify non-oxidative pathways. LC/MS analyses of the stressed solutions revealed that hydrolysis and oxidation are the primary degradation pathways for the studied compound. A a-thiol acetic acid, acyl amide, and two dimeric diastereomers were the main degradates of the insulin sensitizer. The alpha-thiol acetic acid served as an intermediate-like species, and oxidized to two dimeric degradates upon exposing to air. All of them were identified as ring-opening products of the TZD. The entities of the acyl amide and dimeric degradates were respectively verified by a synthetic standard or NMR following isolation of a diastereomeric degradate. Characterization using MS in both positive and negative ion scans were discussed for an isolated diastereomeric degradate. Mechanisms of fragmentation and formation for those degradates are presented based on the MS result. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:209 / 219
页数:11
相关论文
共 19 条
[1]   Dimerizable detergents as gene transfer vectors [J].
Blessing, T ;
Dauty, E ;
Remy, JS ;
Behr, JP .
JOURNAL OF LIPOSOME RESEARCH, 2000, 10 (04) :321-327
[2]   STRUCTURE ACTIVITY RELATIONS .6. THE ALKALINE-HYDROLYSIS OF 3-METHYL-5-METHYLIDENE- AND 3,5-DIMETHYLTHIAZOLIDINE-2,4-DIONES - THE ADDITION OF THIOLS TO 3-METHYL-5-METHYLIDENETHIAZOLIDINE-2,4-DIONE [J].
BOWDEN, K ;
CHANA, RS .
JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 2, 1990, (12) :2163-2166
[3]   DIMERIZATION OF THIOL-SPECIFIC ANTIOXIDANT AND THE ESSENTIAL ROLE OF CYSTEINE-47 [J].
CHAE, HZ ;
UHM, TB ;
RHEE, SG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (15) :7022-7026
[4]   METABOLISM OF A NEW THIAZOLIDINEDIONE HYPOGLYCEMIC AGENT-CP-68,722 IN RAT - METABOLITE IDENTIFICATION BY GAS-CHROMATOGRAPHY MASS-SPECTROMETRY [J].
FOUDA, HG ;
LUKASZEWICZ, J ;
CLARK, DA ;
HULIN, B .
XENOBIOTICA, 1991, 21 (07) :925-934
[5]   Photooxidation of troglitazone, a new antidiabetic drug [J].
Fu, YL ;
Sheu, CM ;
Fujita, T ;
Foote, CS .
PHOTOCHEMISTRY AND PHOTOBIOLOGY, 1996, 63 (05) :615-620
[6]   Differentiating members of the thiazolidinedione class: a focus on efficacy [J].
Goldstein, BJ .
DIABETES-METABOLISM RESEARCH AND REVIEWS, 2002, 18 :S16-S22
[7]   The mode of action of thiazolidinediones [J].
Hauner, H .
DIABETES-METABOLISM RESEARCH AND REVIEWS, 2002, 18 :S10-S15
[8]   Studies on the metabolism of troglitazone to reactive intermediates in vitro and in vivo. Evidence for novel biotransformation pathways involving quinone methide formation and thiazolidinedione ring scission [J].
Kassahun, K ;
Pearson, PG ;
Tang, W ;
McIntosh, L ;
Leung, K ;
Elmore, C ;
Dean, D ;
Wang, R ;
Doss, G ;
Baillie, TA .
CHEMICAL RESEARCH IN TOXICOLOGY, 2001, 14 (01) :62-70
[9]  
Kiyota Y, 1997, ARZNEIMITTEL-FORSCH, V47, P22
[10]   Functional group migration in benzaldoxime-O-n-propyl ether radical cation [J].
Letzel, MC ;
Grützmacher, HF ;
Fürst, T ;
Mayer, KK ;
Wiegrebe, W .
INTERNATIONAL JOURNAL OF MASS SPECTROMETRY, 2002, 217 (1-3) :153-168